Oosthuizen Johannes Jacobus
- SEC CIK
- 0001916310
In the past year, 1 open-market sale filing worth $1.83M and no purchases.
Current role at each company
- MRK Merck & Co., Inc.EVP, Oncology & Int?las of May 7, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $1.83M
- 1 filing
- Net
- −$1.83M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Oosthuizen Johannes Jacobus as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 6, 2026 (view filing) | Feb 6 | Same day | Oosthuizen Johannes JacobusPresident, U.S. Market | SSale | −15.0K | $121.87 | −$1.83M | −41.4%21.2K after | |
| Feb 20, 2025 (view filing) | Feb 19 | 1 day | Oosthuizen Johannes JacobusPresident, U.S. Market | SSale | −8.50K | $84.09 | −$714.8K | −21.7%30.7K after | |
| Feb 5, 2024 (view filing) | Feb 2 | 3 days | Oosthuizen Johannes JacobusPresident, U.S. Market | SSale | −19.0K | $127.18 | −$2.41M | −44.8%23.3K after | |
| Nov 13, 2023 (view filing) | Nov 9 | 4 days | Oosthuizen Johannes JacobusPresident, U.S. Market | SSale | −2.08K | $102.38 | −$213.1K | −10.3%18.2K after | |
| Nov 10, 2022 (view filing) | Nov 9 | 1 day | Oosthuizen Johannes JacobusPresident, U.S. Market | SSale | −1.79K | $103.21 | −$185.3K | −9.7%16.7K after | |
| Nov 7, 2022 (view filing) | Nov 7 | Same day | Oosthuizen Johannes JacobusPresident, U.S. Market | SSale | −45.6K | $99.47 | −$4.53M | −71.1%18.5K after | |
| Nov 1, 2022 (view filing) | Oct 28 | 4 days | Oosthuizen Johannes JacobusPresident, U.S. Market | SSale | −3.63K | $100.21 | −$364.1K | −25.0%10.9K after |